tiprankstipranks
MaaT Pharma (FR:MAAT)
:MAAT
France Market
MAAT
MaaT Pharma
RESEARCH TOOLSreports

MaaT Pharma (MAAT) Stock News & Sentiment

3 Followers
MaaT Pharma: EMA Review, Robust Pipeline, and Solid Cash Runway Underpin Buy Rating and Upside Potential
Premium
Ratings
MaaT Pharma: EMA Review, Robust Pipeline, and Solid Cash Runway Underpin Buy Rating and Upside Potential
13d ago
Promising ALS Trial Results Bolster Buy Rating for MaaT Pharma Amidst Strategic Oncology Focus
Premium
Ratings
Promising ALS Trial Results Bolster Buy Rating for MaaT Pharma Amidst Strategic Oncology Focus
11M ago
Buy Rating for MaaT Pharma Driven by Promising Clinical Developments and Strategic Financial Projections
Premium
Ratings
Buy Rating for MaaT Pharma Driven by Promising Clinical Developments and Strategic Financial Projections
1y ago
Buy Rating for MaaT Pharma: Promising Phase 3 Results and Strategic Growth Catalysts
Premium
Ratings
Buy Rating for MaaT Pharma: Promising Phase 3 Results and Strategic Growth Catalysts
1y ago
MaaT Pharma’s Strong Financial Position and Promising Clinical Developments Drive Buy Rating
Premium
Ratings
MaaT Pharma’s Strong Financial Position and Promising Clinical Developments Drive Buy Rating
1y ago
MaaT Pharma’s Promising Outlook: Buy Rating Backed by Positive DSMB Review and Strong Phase 3 Results for MaaT013
Premium
Ratings
MaaT Pharma’s Promising Outlook: Buy Rating Backed by Positive DSMB Review and Strong Phase 3 Results for MaaT013
1y ago
MaaT Pharma: Buy Rating Affirmed Amid Promising Regulatory Milestones and Market Potential
Premium
Ratings
MaaT Pharma: Buy Rating Affirmed Amid Promising Regulatory Milestones and Market Potential
1y ago
More FR:MAAT News >

MAAT News on the Web

Kepler Capital Sticks to Its Buy Rating for MaaT Pharma (MAAT)
TipRanks News
Bullish
MaaT Pharma: EMA Review, Robust Pipeline, and Solid Cash Runway Underpin Buy Rating and Upside Potential
TipRanks News
Bullish
MaaT Pharma (MAAT) Receives a Buy from Kepler Capital
TipRanks News
Bullish
MaaT Pharma SA's (EPA:MAAT) largest shareholders are private equity firms who were rewarded as market cap surged €15m last week
Simply Wall St
Neutral
MaaT Pharma Reports First Half 2025 Earnings
Simply Wall St
Neutral
Analysts Expect Breakeven For MaaT Pharma SA (EPA:MAAT) Before Long
Simply Wall St
Neutral
Kepler Capital Remains a Buy on MaaT Pharma (MAAT)
TipRanks News
Neutral
MaaT Pharma Reports Full Year 2024 Earnings
Simply Wall St
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is FR:MAAT’s Media Buzz Sentiment?
Currently, no data Available
What is FR:MAAT’s weekly average amount of articles?
Currently, no data Available
What is FR:MAAT’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
AORTArtivion
NBIXNeurocrine
STAAStaar Surgical
SLPSimulations Plus
OWLTOwlet
Showing the stocks with the most bullish news sentiment over the past week